Data suggest that when pharmacological Zn levels used, average daily gain and average daily feed intake can be improved with ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

Similarly, since the late-1990s Toronto has been enjoying another boom, which has resulted in entirely new districts, such as ...

New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...

Human brains do something peculiar when a chimpanzee screams or hoots. Instead of treating those sounds as generic animal ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced a $110 million investment to expand its production of prefillable syringes, helping accelerate ...

(n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...

Exelixis (EXEL) announced an update on their ongoing clinical study.